logo

GRTS(Delisted)

Gritstone bioยทNASDAQ
--
--(--)

GRTS Profile

Gritstone Bio, Inc.

A tumor-specific cancer immunotherapies developer

--
--
09/28/2018
NASDAQ Stock Exchange
231
12-31
Common stock
5959 Horton Street, Suite 300, Emeryville, CA 94608
--
Gritstone bio, Inc., was incorporated in Delaware in August 2015. The company is a clinical-stage biotechnology company focused on combining immunological insights with proprietary technologies and capabilities to develop next-generation vaccines. The company discovers, develops, manufactures and delivers vaccine-based immunotherapy drug candidates for cancer and infectious diseases. The company's goal is to unlock stronger, longer-lasting immunity by leveraging vaccine innovations.